CYP1A1 | Cytochrome P450, family 1, subfamily A, polypeptide 1 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
UPK2 | Uroplakin 2 | Predicted membrane proteins
| | | | | Tissue enriched |
CAPNS2 | Calpain, small subunit 2 | | | | | | Group enriched |
PADI3 | Peptidyl arginine deiminase, type III | Enzymes
| | | | | Group enriched |
GRHL3 | Grainyhead-like 3 (Drosophila) | Predicted secreted proteins Transcription factors
| | | | | Group enriched |
PLA2G2F | Phospholipase A2, group IIF | Enzymes Predicted membrane proteins RAS pathway related proteins
| | | | | Group enriched |
CHRDL2 | Chordin-like 2 | Predicted secreted proteins
| | | | | Group enriched |
HOXA13 | Homeobox A13 | Cancer-related genes Disease related genes Transcription factors
| | | | | Group enriched |
DHRS2 | Dehydrogenase/reductase (SDR family) member 2 | | | | | | Group enriched |
SERPINB4 | Serpin peptidase inhibitor, clade B (ovalbumin), member 4 | Cancer-related genes Plasma proteins
| | | | | Group enriched |
UPK3B | Uroplakin 3B | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
TTLL8 | Tubulin tyrosine ligase-like family, member 8 | | | | | | Group enriched |
UPK3A | Uroplakin 3A | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
BPIFA1 | BPI fold containing family A, member 1 | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
IL24 | Interleukin 24 | Cancer-related genes Predicted secreted proteins
| | | | | Group enriched |
NOS2 | Nitric oxide synthase 2, inducible | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Group enriched |
RBFOX3 | RNA binding protein, fox-1 homolog (C. elegans) 3 | | | | | | Group enriched |
UPK1A | Uroplakin 1A | Predicted membrane proteins
| | | | | Group enriched |
ACOXL | Acyl-CoA oxidase-like | | | | | | Group enriched |
IL19 | Interleukin 19 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
KIAA1644 | KIAA1644 | Predicted membrane proteins
| | | | | Group enriched |
LYPD6B | LY6/PLAUR domain containing 6B | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
SELL | Selectin L | Cancer-related genes Candidate cardiovascular disease genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
SNX31 | Sorting nexin 31 | Cytoskeleton related proteins Transporters
| | | | | Group enriched |
AC007382.1 | Uncharacterized protein | | | | | | Tissue enhanced |
AC018816.3 | Uncharacterized protein | | | | | | Tissue enhanced |
AC142381.1 | | | | | | | Tissue enhanced |
ACER2 | Alkaline ceramidase 2 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
ALG1L | ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase-like | | | | | | Tissue enhanced |
ATP1A4 | ATPase, Na+/K+ transporting, alpha 4 polypeptide | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
BDKRB1 | Bradykinin receptor B1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
BMP3 | Bone morphogenetic protein 3 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
BTBD16 | BTB (POZ) domain containing 16 | | | | | | Tissue enhanced |
CCR4 | Chemokine (C-C motif) receptor 4 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CCR8 | Chemokine (C-C motif) receptor 8 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CHI3L1 | Chitinase 3-like 1 (cartilage glycoprotein-39) | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CLEC3A | C-type lectin domain family 3, member A | Predicted secreted proteins
| | | | | Tissue enhanced |
CLLU1OS | Chronic lymphocytic leukemia up-regulated 1 opposite strand | | | | | | Tissue enhanced |
CTHRC1 | Collagen triple helix repeat containing 1 | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
CXCL1 | Chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CXCL5 | Chemokine (C-X-C motif) ligand 5 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CXCL6 | Chemokine (C-X-C motif) ligand 6 | Predicted secreted proteins
| | | | | Tissue enhanced |
CYP24A1 | Cytochrome P450, family 24, subfamily A, polypeptide 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Tissue enhanced |
DKK1 | Dickkopf WNT signaling pathway inhibitor 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
DUOXA2 | Dual oxidase maturation factor 2 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
EDARADD | EDAR-associated death domain | Disease related genes
| | | | | Tissue enhanced |
FAM150A | Family with sequence similarity 150, member A | Predicted secreted proteins
| | | | | Tissue enhanced |
FOXQ1 | Forkhead box Q1 | Cancer-related genes Transcription factors
| | | | | Tissue enhanced |
FSTL4 | Follistatin-like 4 | Predicted secreted proteins
| | | | | Tissue enhanced |
GPR110 | G protein-coupled receptor 110 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |